| NCT ID | NCT06093464 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-04-16 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-04-16 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to explore the positive, holistic health outcomes resulting from regular exposure to naturally occurring compounds predicted to have health benefits. The researchers hope to learn how the human body is influenced by regular exposure to these compounds.
Eligibility Criteria
Inclusion Criteria: * 18 years of age and older * Read, speak, and understand English * Live in the US territory Exclusion Criteria: * Mental incapacity and/or cognitive impairment on the part of the patient that would preclude adequate understanding of, or cooperation with, the study protocol * Is pregnant * Is breastfeeding * Has epilepsy * Has allergies to Cupressaceae family of plants, common plants include redwoods, junipers, cypress, cedar, fir, and sequoia
Contact & Investigator
Michael Snyder, PhD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT06093464 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06093464 currently recruiting?
Yes, NCT06093464 is actively recruiting participants. Contact the research team at jikimji@stanford.edu for enrollment information.
Where is the NCT06093464 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT06093464 clinical trial?
NCT06093464 is sponsored by Stanford University. The principal investigator is Michael Snyder, PhD at Stanford University. The trial plans to enroll 40 participants.